StockData
Elutia Inc. logo

Elutia Inc. (ELUT) stock

ELUTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 9/307% below fair value
$0.83−0.02 (-2.80%)

Close on Nov 18, 2026Market cap $36.76MP/E –Yield –

Elutia revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Elutia's revenue for the twelve months ending Jun 30, 2026 was $12.14M, down 0.3% year over year. For fiscal 2025 it was $12.29M, down 15.0% from the year before. The highest annual figure on record is $47.39M in fiscal 2021.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$12.29M-15.0%
FY2024Dec 31, 2024$14.47M-41.5%
FY2023Dec 31, 2023$24.75M+3.8%
FY2022Dec 31, 2022$23.85M-49.7%
FY2021Dec 31, 2021$47.39M+11.0%
FY2020Dec 31, 2020$42.68M-0.5%
FY2019Dec 31, 2019$42.90M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.43M-11.6%
Q1 FY2026Mar 31, 2026$3.11M+5.5%
Q4 FY2025Dec 31, 2025$3.27M+16.2%
Q3 FY2025Sep 30, 2025$3.32M-9.3%
Q2 FY2025Jun 30, 2025$2.75M-56.3%
Q1 FY2025Mar 31, 2025$2.95M-55.9%
Q4 FY2024Dec 31, 2024$2.82M-52.1%
Q3 FY2024Sep 30, 2024$3.66M-40.2%
Q2 FY2024Jun 30, 2024$6.29M-0.9%
Q1 FY2024Mar 31, 2024$6.69M+4.7%
Q4 FY2023Dec 31, 2023$5.88M-53.5%
Q3 FY2023Sep 30, 2023$6.13M-46.7%
Q2 FY2023Jun 30, 2023$6.35M-41.5%
Q1 FY2023Mar 31, 2023$6.39M-44.3%
Q2 FY2022Jun 30, 2022$12.64M+3.9%
Q1 FY2022Mar 31, 2022$11.50M-10.8%
Q4 FY2021Dec 31, 2021$10.86M-12.9%
Q3 FY2021Sep 30, 2021$11.49M-2.5%
Q2 FY2021Jun 30, 2021$12.16M+41.7%
Q1 FY2021Mar 31, 2021$12.88M+30.6%
Q4 FY2020Dec 31, 2020$12.47M+3.4%
Q3 FY2020Sep 30, 2020$11.77M+5.7%
Q2 FY2020Jun 30, 2020$8.58M–
Q1 FY2020Mar 31, 2020$9.86M–
Q4 FY2019Dec 31, 2019$12.05M–
Q3 FY2019Sep 30, 2019$11.14M–

More Elutia figures

See a number that looks wrong?